Internal Medicine, Rheumatology · Old Bridge, NJ
NPI
1821163437
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3 Hospital Plz, Suite 409
Old Bridge, NJ, 08857
Phone (732) 869-1002
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
145,185 services
Medicare patients, 2024
1,114
Average age 73
Drug cost, 2024
$5.3M
9,034 prescriptions
Company payments, 2025
$3,649
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wadie Toma was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 85,201 times for 25 patients. In total Wadie Toma billed 145,185 services in 29 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 85,201 | 25 | $3.63 | $309K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 15,051 | 20 | $33.94 | $511K |
| J0897 Injection, denosumab, 1 mg | Office | 9,540 | 94 | $20.58 | $196K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 8,540 | 15 | $9.05 | $77K |
| 99214 Office E&M - Established | Office | 1,610 | 786 | $101.26 | $163K |
| 99213 Office E&M - Established | Office | 1,197 | 538 | $73.12 | $88K |
| 96401 Chemotherapy Administration | Office | 876 | 135 | $64.24 | $56K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 820 | 62 | $0.76 | $620 |
| 96413 Chemotherapy Administration | Office | 291 | 39 | $112.76 | $33K |
| 20610 Joint Injection | Office | 185 | 78 | $55.14 | $10K |
| 99204 Office E&M - New | Office | 148 | 148 | $129.39 | $19K |
| 99205 Office E&M - New | Office | 126 | 126 | $163.63 | $21K |
| J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 66 | 36 | $401.89 | $27K |
| 96372 Injection Administration | Office | 35 | 11 | $12.72 | $445 |
By year: 2022 $1.5M for 109,160 services; 2023 $1.6M for 133,020 services; 2024 $1.8M for 145,185 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wadie Toma prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,552 prescriptions and refills. In total Wadie Toma wrote 9,034 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,552 | 2,781 | 380 | $67K |
| Methotrexate Methotrexate Sodium | 1,394 | 2,126 | 285 | $32K |
| Prednisone Generic | 1,040 | 1,412 | 308 | $6,771 |
| Leflunomide Generic | 513 | 767 | 110 | $32K |
| Tizanidine Hcl Generic | 504 | 735 | 154 | $3,498 |
| Gabapentin Generic | 357 | 466 | 86 | $5,108 |
| Meloxicam Generic | 281 | 383 | 86 | $1,089 |
| Sulfasalazine Dr Sulfasalazine | 275 | 380 | 56 | $8,324 |
| Diclofenac Sodium Generic | 249 | 309 | 69 | $15K |
| Sulindac Generic | 230 | 271 | 104 | $3,240 |
| Celecoxib Generic | 203 | 269 | 56 | $4,844 |
| Allopurinol Generic | 196 | 442 | 52 | $1,825 |
| Humira(Cf) Pen Adalimumab | 130 | 157 | 20 | $1.2M |
| Folic Acid Generic | 128 | 250 | 35 | $1,168 |
| Duloxetine Hcl Generic | 127 | 185 | 28 | $1,639 |
Brand drugs: 1,084 claims; generic drugs: 7,950 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wadie Toma $3,649 ($3,649 in general payments such as food, travel and fees) from 18 companies. The largest payer was Janssen Biotech, Inc. with $1,082.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 17 | $1,082 |
| Amgen Inc. AMGN | 19 | $672 |
| UCB, Inc. UCB.BR | 16 | $355 |
| Abbvie Inc. ABBV | 14 | $293 |
| GlaxoSmithKline, LLC. GSK | 14 | $290 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $250 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $193 |
| Pfizer Inc. PFE | 7 | $124 |
| Genentech USA, Inc. ROG.SW | 5 | $76 |
| Organon LLC OGN | 5 | $75.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.